| Literature DB >> 33419931 |
Qi Jin1, Ni Shi2, Desmond Aroke2, Dong Hoon Lee3, Joshua J Joseph4, Macarius Donneyong5, Darwin L Conwell6, Phil A Hart6, Xuehong Zhang3,7, Steven K Clinton1,2,8, Zobeida Cruz-Monserrate1,2,6, Theodore M Brasky2,8, Rebecca Jackson4, Lesley F Tinker9, Simin Liu10, Lawrence S Phillips11,12, Aladdin H Shadyab13, Rami Nassir14, Wei Bao15, Fred K Tabung16,2,3,8,17.
Abstract
OBJECTIVE: The empirical dietary index for hyperinsulinemia (EDIH) and empirical dietary inflammatory pattern (EDIP) scores assess the insulinemic and inflammatory potentials of habitual dietary patterns, irrespective of the macronutrient content, and are based on plasma insulin response or inflammatory biomarkers, respectively. The glycemic index (GI) and glycemic load (GL) assess postprandial glycemic potential based on dietary carbohydrate content. We tested the hypothesis that dietary patterns promoting hyperinsulinemia, chronic inflammation, or hyperglycemia may influence type 2 diabetes risk. RESEARCH DESIGN AND METHODS: We calculated dietary scores from baseline (1993-1998) food frequency questionnaires among 73,495 postmenopausal women in the Women's Health Initiative, followed through March 2019. We used multivariable-adjusted Cox regression to estimate hazard ratios (HRs) and 95% CIs for type 2 diabetes risk. We also estimated multivariable-adjusted absolute risk of type 2 diabetes.Entities:
Year: 2021 PMID: 33419931 PMCID: PMC7896263 DOI: 10.2337/dc20-2216
Source DB: PubMed Journal: Diabetes Care ISSN: 0149-5992 Impact factor: 19.112
Baseline characteristics of study participants across quintiles of dietary patterns scores, WHI (n = 73,495)
| EDIH | EDIP | GI | GL | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Q1 | Q3 | Q5 | Q1 | Q3 | Q5 | Q1 | Q3 | Q5 | Q1 | Q3 | Q5 | |
| Characteristic | (−9.67 to −0.89) | (−0.36 to 0.05) | (0.54–8.89) | (−11.90 to −0.89) | (−0.26 to 0.19) | (0.68–6.01) | (−12.13 to −0.58) | (−0.08 to 0.35) | (0.85–3.71) | (−8.35 to −0.46) | (0.04–0.46) | (0.98–8.06) |
| Race/ethnicity | ||||||||||||
| African American | 517 (3.5) | 786 (5.3) | 1,602 (11) | 398 (2.7) | 732 (5.0) | 1,891 (13) | 585 (4.0) | 755 (5.1) | 1,714 (12) | 785 (5.3) | 878 (6.0) | 1,178 (8.0) |
| American Indian or Alaskan Native | 27 (0.2) | 55 (0.4) | 66 (0.5) | 43 (0.3) | 44 (0.3) | 78 (0.5) | 61 (0.4) | 41 (0.3) | 63 (0.4) | 53 (0.4) | 55 (0.4) | 47 (0.3) |
| Hispanic American | 360 (2.4) | 486 (3.3) | 760 (5.2) | 203 (1.4) | 390 (2.6) | 1,168 (7.9) | 596 (4.0) | 491 (3.3) | 495 (3.4) | 557 (3.8) | 510 (3.5) | 490 (3.3) |
| Asian or Pacific Islander | 313 (2.1) | 486 (3.3) | 411 (2.8) | 197 (1.3) | 332 (2.3) | 806 (5.5) | 382 (2.6) | 475 (3.2) | 334 (2.3) | 259 (1.8) | 474 (3.2) | 469 (3.2) |
| European American | 13,269 (90) | 12,709 (86) | 11,633 (79) | 13,670 (93) | 12,997 (88) | 10,499 (71) | 12,854 (88) | 12,741 (87) | 11,887 (81) | 12,869 (88) | 12,552 (85) | 12,289 (84) |
| Other | 213 (1.5) | 177 (1.2) | 227 (1.5) | 188 (1.3) | 204 (1.4) | 257 (1.8) | 221 (1.5) | 196 (1.3) | 206 (1.4) | 176 (1.2) | 230 (1.6) | 226 (1.5) |
| Age, years | 62.9 ± 7.2 | 63.6 ± 7.3 | 62.2 ± 7.3 | 62.7 ± 7.1 | 63.5 ± 7.3 | 62.5 ± 7.4 | 63.5 ± 7.3 | 63.2 ± 7.3 | 62.4 ± 7.2 | 63.1 ± 7.2 | 63.4 ± 7.3 | 62.4 ± 7.3 |
| BMI, kg/m2 | 25.6 ± 4.7 | 26.4 ± 5.1 | 28.7 ± 6.2 | 26.1 ± 4.9 | 26.5 ± 5.2 | 28.1 ± 6.1 | 26.3 ± 5.1 | 26.7 ± 5.3 | 27.5 ± 5.7 | 27.4 ± 5.8 | 26.6 ± 5.2 | 26.6 ± 5.4 |
| Under-/normal weight (15 ≤ BMI <25) | 7,686 (52) | 6,611 (45) | 4,454 (30) | 7,038 (48) | 6,471 (44) | 5,029 (34) | 6,801 (46) | 6,343 (43) | 5,582 (38) | 5,739 (39) | 6,389 (44) | 6,650 (45) |
| Overweight (25 ≤ BMI <30) | 4,797 (33) | 5,075 (34) | 4,924 (34) | 5,006 (34) | 5,136 (35) | 4,883 (33) | 5,401 (34) | 5,080 (35) | 4,953 (34) | 4,943 (34) | 5,132 (35) | 4,821 (33) |
| Obese (BMI ≥30) | 2,216 (15) | 3,013 (20) | 5,321 (36) | 2,655 (18) | 3,092 (21) | 4,787 (33) | 2,857 (19) | 3,276 (22) | 4,164 (28) | 4,017 (27) | 3,178 (22) | 3,228 (22) |
| WHR | 0.79 ± 0.08 | 0.80 ± 0.08 | 0.82 ± 0.08 | 0.79 ± 0.08 | 0.80 ± 0.08 | 0.82 ± 0.08 | 0.80 ± 0.08 | 0.80 ± 0.08 | 0.81 ± 0.08 | 0.81 ± 0.08 | 0.80 ± 0.08 | 0.80 ± 0.08 |
| ≤0.85 | 12,062 (82) | 11,535 (78) | 9,986 (68) | 11,833 (80) | 11,362 (77) | 10,169 (69) | 11,568 (79) | 11,307 (77) | 10,709 (73) | 10,595 (72) | 11,393 (78) | 11,452 (78) |
| >0.85 | 2,637 (18) | 3,164 (22) | 4,713 (32) | 2,866 (20) | 3,337 (23) | 4,530 (31) | 3,131 (21) | 3,392 (23) | 3,990 (27) | 11,568 (28) | 11,307 (22) | 10,709 (22) |
| Physical activity, MET-h/week | 18.1 ± 16.4 | 14.2 ± 14.1 | 9.6 ± 12.0 | 16.6 ± 15.6 | 14.1 ± 14.1 | 10.8 ± 13.1 | 17.3 ± 16.0 | 14.2 ± 14.2 | 10.3 ±12.6 | 12.0 ± 13.5 | 14.0 ± 14.1 | 16.2 ± 15.9 |
| Pack-years of smoking | 10.7 ± 17.9 | 9.1 ± 17.0 | 10.6 ± 19.5 | 12.9 ± 19.9 | 9.3 ± 17.2 | 8.0 ± 16.7 | 9.9 ± 17.6 | 9.1 ± 16.8 | 10.8 ± 19.2 | 13.9 ± 21.2 | 8.6 ± 16.2 | 8.1 ± 16.2 |
| Current smoking | 859 (5.9) | 859 (5.9) | 1,559 (11) | 1,283 (8.9) | 900 (6.2) | 1,060 (7.3) | 828 (5.7) | 888 (6.1) | 1,531 (11) | 1,864 (13) | 801 (5.5) | 658 (4.5) |
| Aspirin/NSAIDs use | 1,980 (14) | 1,942 (13) | 1,891 (13) | 2,103 (14) | 2,001 (14) | 1,802 (12) | 1,994 (14) | 1,966 (13) | 1,982 (14) | 2,020 (14) | 2,013 (14) | 1,860 (13) |
| Statin use | 293 (2.0) | 342 (2.3) | 307 (2.1) | 270 (1.8) | 327 (2.2) | 341 (2.3) | 286 (2.0) | 314 (2.1) | 320 (2.2) | 200 (1.4) | 340 (2.3) | 395 (2.7) |
| Hypercholesterolemia | 1,603 (11) | 1,824 (12) | 1,806 (12) | 1,518 (10) | 1,850 (13) | 1,944 (13) | 1,601 (11) | 1,815 (12) | 1,884 (13) | 1,372 (9.3) | 1,827 (12) | 2,108 (14) |
| Educational level | ||||||||||||
| ≤8 years | 238 (1.6) | 280 (1.9) | 425 (2.9) | 167 (1.1) | 232 (1.6) | 599 (4.1) | 287 (2.0) | 275 (1.9) | 392 (2.7) | 326 (2.2) | 316 (2.2) | 309 (2.1) |
| Some high school/high school/GED | 388 (2.7) | 474 (3.3) | 846 (5.8) | 376 (2.6) | 469 (3.2) | 858 (5.9) | 358 (2.5) | 476 (3.3) | 890 (6.1) | 583 (4.0) | 503 (3.4) | 531 (3.7) |
| Some college/associate degree | 2,932 (20) | 3,901 (27) | 4,967 (34) | 3,328 (23) | 3,882 (27) | 4,719 (32) | 2,977 (20) | 3,829 (26) | 5,186 (36) | 4,141 (28) | 3,953 (27) | 3,655 (25) |
| ≥4 years of college | 10,975 (76) | 9,946 (68) | 8,384 (57) | 10,687 (73) | 10,007 (69) | 8,430 (58) | 10,947 (75) | 10,016 (69) | 8,129 (56) | 9,536 (65) | 9,824 (67) | 10,065 (69) |
| Total alcohol intake, servings/week | 5.4 ± 8.2 | 2.1 ± 4.0 | 1.7 ± 4.0 | 5.9 ± 8.5 | 2.2 ± 3.9 | 1.0 ± 2.9 | 3.8 ± 6.9 | 2.7 ± 4.7 | 1.9 ± 4.7 | 6.1 ± 8.9 | 2.0 ± 3.4 | 1.2 ± 2.8 |
GED, General Educational Development; NSAID, nonsteroidal anti-inflammatory drug.
EDIP, EDIH, GI, and GL scores were adjusted for total energy intake using the residual method. Lower EDIP indicates anti-inflammatory dietary patterns, while higher EDIP scores indicate proinflammatory dietary patterns. Lower EDIH indicates low insulinemic dietary patterns, while a higher score indicates hyperinsulinemic dietary patterns.
Food components of the EDIH and EDIP scores (servings per day) in the WHI are listed in Supplementary Tables 3 and 4.
GI and GL were calculated from total carbohydrates.
Alcohol serving was the sum of: beer (one glass, one bottle, or one can), wine (4-oz glass of red wine or white wine), and liquor (one drink or one shot whiskey, gin, etc.).
Data are means ± SD.
Data are frequency (%).
HRs (95% CI) for the associations of dietary patterns with risk of developing type 2 diabetes*†‡
| Dietary indices | Quintile 1 | Quintile 2 | Quintile 3 | Quintile 4 | Quintile 5 | Per 1-SD increment | |
|---|---|---|---|---|---|---|---|
| EDIH | |||||||
| Case subjects/noncase subjects | 1,944/12,755 | 1,988/12,711 | 2,078/12,621 | 2,267/12,432 | 2,732/11,967 | — | — |
| Age and energy adjusted | 1 (reference) | 1.07 (1.01–1.14) | 1.17 (1.10–1.24) | 1.30 (1.22–1.38) | 1.65 (1.56–1.75) | 1.19 (1.17–1.21) | <0.0001 |
| MV adjusted | 1 (reference) | 1.09 (0.96–1.25) | 1.11 (0.98–1.26) | 1.19 (1.05–1.35) | 1.49 (1.32–1.68) | 1.14 (1.10–1.18) | <0.0001 |
| MV+BMI adjusted | 1 (reference) | 1.15 (0.96–1.37) | 1.02 (0.86–1.21) | 1.17 (0.99–1.38) | 1.41 (1.20–1.65) | 1.12 (1.07–1.17) | <0.0001 |
| EDIP | |||||||
| Case subjects/noncase subjects | 1,981/12,718 | 19,91/12,708 | 2,073/12,626 | 2,268/12,431 | 2,696/12,003 | — | — |
| Age and energy adjusted | 1 (reference) | 1.03 (0.97–1.10) | 1.08 (1.01–1.14) | 1.27 (1.19–1.34) | 1.60 (1.51–1.69) | 1.18 (1.16–1.20) | <0.0001 |
| MV adjusted | 1 (reference) | 1.06 (0.94–1.21) | 1.10 (0.97–1.24) | 1.25 (1.11–1.41) | 1.45 (1.29–1.63) | 1.15 (1.11–1.19) | <0.0001 |
| MV+BMI adjusted | 1 (reference) | 1.00 (0.85–1.18) | 1.08 (0.92–1.27) | 1.27 (1.09–1.49) | 1.42 (1.22–1.65) | 1.14 (1.09–1.19) | <0.0001 |
| GI | |||||||
| Case subjects/noncase subjects | 2,143/12,556 | 2,144/12,555 | 2,187/12,512 | 2,264/12,435 | 2,271/12,428 | — | — |
| Age and energy adjusted | 1 (reference) | 1.01 (0.95–1.08) | 1.03 (0.97–1.10) | 1.10 (1.03–1.16) | 1.22 (1.15–1.30) | 1.08 (1.05–1.10) | <0.0001 |
| MV adjusted | 1 (reference) | 1.00 (0.88–1.14) | 1.03 (0.91–1.16) | 0.95 (0.84–1.07) | 0.99 (0.88–1.12) | 0.99 (0.95–1.03) | 0.46 |
| MV+BMI adjusted | 1 (reference) | 1.05 (0.89–1.23) | 0.93 (0.79–1.10) | 0.92 (0.79–1.08) | 0.99 (0.85–1.16) | 0.97 (0.92–1.03) | 0.31 |
| GL | |||||||
| Case subjects/noncase subjects | 2,288/12,411 | 2,172/12,527 | 2,161/12,538 | 2,146/12,553 | 2,242/12,457 | — | — |
| Age and energy adjusted | 1 (reference) | 0.94 (0.89–1.00) | 0.93 (0.87–0.98) | 0.88 (0.83–0.93) | 0.91 (0.86–0.96) | 0.97 (0.95–0.99) | 0.0012 |
| MV adjusted | 1 (reference) | 0.97 (0.87–1.09) | 0.93 (0.83–1.05) | 0.97 (0.85–1.10) | 1.01 (0.89–1.16) | 1.02 (0.98–1.07) | 0.30 |
| MV+BMI adjusted | 1 (reference) | 0.90 (0.78–1.04) | 0.94 (0.80–1.10) | 0.94 (0.80–1.11) | 0.97 (0.81–1.15) | 0.99 (0.94–1.05) | 0.71 |
EDIP, EDIH, GI, and GL scores were adjusted for total energy intake using the residual method. The EDIH, EDIP, and GI (total carbohydrates) multivariable (MV)-adjusted models were stratified by age, hypertension, family history of type 2 diabetes, hormone use, physical activity, and further adjusted for education, race, pack-years of smoking, high cholesterol, WHI study arms, nonsteroidal anti-inflammatory drug use, statin use, and nutritional supplement use. The MV+BMI models adjusted for all covariates in the MV models and additionally for BMI. The MV-adjusted models for GL were additionally adjusted for total fat, total protein, and dietary fiber. Supplementary Tables 3 and 4 list food components of EDIH and EDIP.
Lower EDIP scores indicate anti-inflammatory dietary patterns, while higher EDIP scores indicate proinflammatory patterns. Lower EDIH indicates antihyperinsulinemic dietary patterns, while a higher score indicates prohyperinsulinemic patterns.
GI and GL were calculated using total carbohydrates and available carbohydrates. Results were similar; thus, we used only scores from total carbohydrate. Lower GI/GL scores indicate low glycemic diets, while higher scores indicate hyperglycemic diets.
P values for linear trend across dietary index quintiles were estimated using the dietary indices entered into the models as continuous variables. Models for linear trend were adjusted for all covariates listed in the corresponding models in the footnote above marked with an asterisk (*).
Incidence rate of type 2 diabetes (per 100,000 person-years) in dietary index quintiles*
| Dietary indices | Type 2 diabetes incidence rate (per 100,000 person-years) | |||||
|---|---|---|---|---|---|---|
| Quintile 1 | Quintile 2 | Quintile 3 | Quintile 4 | Quintile 5 | Q5 − Q1 | |
| EDIH | 1,160 | 1,195 | 1,148 | 1,161 | 1,380 | 220 |
| EDIP | 1,116 | 1,142 | 1,170 | 1,233 | 1,387 | 271 |
| GI | 1,220 | 1,241 | 1,180 | 1,195 | 1,201 | −19 |
| GL | 1,281 | 1,181 | 1,176 | 1,160 | 1,240 | −41 |
Each dietary score was adjusted for total energy intake, baseline age, hypertension, type 2 diabetes family history, hormone use, physical activity, education, race, pack-years of smoking, high cholesterol, WHI study arms, nonsteroidal anti-inflammatory drug use, statin use, nutritional supplement use, and BMI. The incidence rate by GL quintiles was further adjusted for total fat, total protein, and dietary fiber.
Q5 − Q1: The excess incidence due to consuming a hyperinsulinemic/proinflammatory or hyperglycemic dietary pattern.
GI and GL were calculated using total carbohydrates.
Figure 1Type 2 diabetes (T2D) incidence rate per 100,000 person-years by race/ethnicity. A: EDIH. B: EDIP. C: GI. D: GL. Each dietary score was adjusted for total energy intake, baseline age, hypertension, family history of type 2 diabetes, hormone use, physical activity, education, race, pack-years of smoking, high cholesterol, WHI study arms, nonsteroidal anti-inflammatory drug use, statin use, nutritional supplement use, and BMI (continuous). The GL (total carbohydrates) was additionally adjusted for total fat, total protein, and dietary fiber. AA, African American; EA, European American; HP, Hispanic American; OA, other American; Q, quintile.